Nebulised salbutamol: an antidote for beta blockers.
dc.contributor.author | Arora, P | en_US |
dc.contributor.author | Kumar, V | en_US |
dc.contributor.author | Dubey, N K | en_US |
dc.contributor.author | Mahesh, K | en_US |
dc.date.accessioned | 1999-06-29 | en_US |
dc.date.accessioned | 2009-05-27T05:05:27Z | |
dc.date.available | 1999-06-29 | en_US |
dc.date.available | 2009-05-27T05:05:27Z | |
dc.date.issued | 1999-06-29 | en_US |
dc.description.affiliation | Department of Pediatrics, Kalawati Saran Children's Hospital, Lady Hardinge Medical College, Bangla Sahib Marg, New Delhi 110 001, India. | en_US |
dc.identifier.citation | Arora P, Kumar V, Dubey NK, Mahesh K. Nebulised salbutamol: an antidote for beta blockers. Indian Pediatrics. 1999 Jun; 36(6): 591-3 | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/8094 | |
dc.language.iso | eng | en_US |
dc.source.uri | https://indianpediatrics.net | en_US |
dc.subject.mesh | Acute Disease | en_US |
dc.subject.mesh | Administration, Inhalation | en_US |
dc.subject.mesh | Adrenergic beta-Agonists --therapeutic use | en_US |
dc.subject.mesh | Adrenergic beta-Antagonists --adverse effects | en_US |
dc.subject.mesh | Albuterol --therapeutic use | en_US |
dc.subject.mesh | Atenolol --adverse effects | en_US |
dc.subject.mesh | Bradycardia --chemically induced | en_US |
dc.subject.mesh | Child | en_US |
dc.subject.mesh | Electrocardiography | en_US |
dc.subject.mesh | Glomerulonephritis --drug therapy | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Nebulizers and Vaporizers | en_US |
dc.title | Nebulised salbutamol: an antidote for beta blockers. | en_US |
dc.type | Case Reports | en_US |
dc.type | Journal Article | en_US |
Files
License bundle
1 - 1 of 1